Novo Nordisk A/S
Industry / private company
Location:
Kopenhagen (Copenhagen),
Denmark (DK)
ISNI: 0000000403912646
ROR: https://ror.org/0435rc536
Show on Map:
Animal Models of Rheumatoid Arthritis (I): Pristane-Induced Arthritis in the Rat (2016)
Tuncel J, Haag S, Hoffmann M, Yau ACY, Hultqvist M, Olofsson P, Backlund J, et al.
Journal article
LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial (2016)
Petrie JR, Marso SP, Bain SC, Franek E, Jacob S, Masmiquel L, Leiter LA, et al.
Journal article
Prediction of beam hardening artefacts in computed tomography using Monte Carlo simulations (2015)
Thomsen M, Knudsen EB, Willendrup PK, Bech M, Willner M, Pfeiffer F, Poulsen M, et al.
Journal article
LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial: preliminary observations (2015)
Daniels GH, Hegedus L, Marso SP, Nauck MA, Zinman B, Bergenstal RM, Mann J, et al.
Journal article